Literature DB >> 22274557

Targeted endothelial gene delivery by ultrasonic destruction of magnetic microbubbles carrying lentiviral vectors.

Hanna Mannell1, Joachim Pircher, Thomas Räthel, Katharina Schilberg, Katrin Zimmermann, Alexander Pfeifer, Olga Mykhaylyk, Bernhard Gleich, Ulrich Pohl, Florian Krötz.   

Abstract

PURPOSE: Site specific vascular gene delivery is a promising tool for treatment of cardiovascular diseases. By combining ultrasound mediated microbubble destruction with site specific magnetic targeting of lentiviruses, we aimed to develop a technique suitable for systemic application.
METHODS: The magnetic nanoparticle coupling to lipid microbubbles was confirmed by absorbance measurements. Association of fluorescent lentivirus to magnetic microbubbles (MMB) was determined by microscopy and flow cytometry. Functionality and efficiency of GFP-encoding lentiviral MMB transduction was evaluated by endothelial (HMEC) GFP expression and cytotoxicity was measured by MTT reduction.
RESULTS: Microbubbles with a mean diameter of 4.3 ± 0.04 μm were stable for 2 days, readily magnetizable and magnetically steerable in vitro and efficiently associated with lentivirus. Exposure of eGFP-encoding lentiviral MMB to human endothelial cells followed by application of an external static magnetic field (30 min) and ultrasonic destruction of the microbubbles did not markedly affect cellular viability. Finally, this combination led to a 30-fold increase in transduction efficiency compared to application of naked virus alone.
CONCLUSIONS: By associating microbubbles with magnetic iron nanoparticles, these function as carriers for lentiviruses achieving tissue specific deposition at the site of interest.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22274557     DOI: 10.1007/s11095-012-0678-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  27 in total

Review 1.  Encapsulated ultrasound microbubbles: therapeutic application in drug/gene delivery.

Authors:  Yiyao Liu; Hirokazu Miyoshi; Michihiro Nakamura
Journal:  J Control Release       Date:  2006-05-27       Impact factor: 9.776

2.  Targeted retroviral gene delivery using ultrasound.

Authors:  Sarah L Taylor; Ahad A Rahim; Nigel L Bush; Jeffrey C Bamber; Colin D Porter
Journal:  J Gene Med       Date:  2007-02       Impact factor: 4.565

3.  Generation of magnetic nonviral gene transfer agents and magnetofection in vitro.

Authors:  Olga Mykhaylyk; Yolanda Sánchez Antequera; Dialekti Vlaskou; Christian Plank
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

4.  Recent advances in magnetofection and its potential to deliver siRNAs in vitro.

Authors:  Olga Mykhaylyk; Olivier Zelphati; Edelburga Hammerschmid; Martina Anton; Joseph Rosenecker; Christian Plank
Journal:  Methods Mol Biol       Date:  2009

5.  New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization.

Authors:  Steliyan Tinkov; Conrad Coester; Susanne Serba; Nicolas A Geis; Hugo A Katus; Gerhard Winter; Raffi Bekeredjian
Journal:  J Control Release       Date:  2010-09-22       Impact factor: 9.776

6.  Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields.

Authors:  Michael Chorny; Ilia Fishbein; Benjamin B Yellen; Ivan S Alferiev; Marina Bakay; Srinivas Ganta; Richard Adamo; Mansoor Amiji; Gary Friedman; Robert J Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

7.  Double-labelled HIV-1 particles for study of virus-cell interaction.

Authors:  Marko Lampe; John A G Briggs; Thomas Endress; Bärbel Glass; Stefan Riegelsberger; Hans-Georg Kräusslich; Don C Lamb; Christoph Bräuchle; Barbara Müller
Journal:  Virology       Date:  2006-11-09       Impact factor: 3.616

8.  New efficient catheter-based system for myocardial gene delivery.

Authors:  Ronen Beeri; J Luis Guerrero; Gregory Supple; Suzanne Sullivan; Robert A Levine; Roger J Hajjar
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690

9.  Combined targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticles.

Authors:  Andreas Hofmann; Daniela Wenzel; Ulrich M Becher; Daniel F Freitag; Alexandra M Klein; Dietmar Eberbeck; Maike Schulte; Katrin Zimmermann; Christian Bergemann; Bernhard Gleich; Wilhelm Roell; Thomas Weyh; Lutz Trahms; Georg Nickenig; Bernd K Fleischmann; Alexander Pfeifer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-31       Impact factor: 11.205

10.  Expression of thymidine kinase mediated by a novel non-viral delivery system under the control of vascular endothelial growth factor receptor 2 promoter selectively kills human umbilical vein endothelial cells.

Authors:  Ying Wang; Hui-Xiong Xu; Ming-De Lu; Qing Tang
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

View more
  8 in total

1.  Novel dual-mode nanobubbles as potential targeted contrast agents for female tumors exploration.

Authors:  Hengli Yang; Tian Zhou; Wenbin Cai; Xiaomin Yi; Xi Liu; Yixiao Wang; Li Zhang; Yunyou Duan
Journal:  Tumour Biol       Date:  2016-08-19

2.  HIF-1α Dependent Wound Healing Angiogenesis In Vivo Can Be Controlled by Site-Specific Lentiviral Magnetic Targeting of SHP-2.

Authors:  Yvonn Heun; Kristin Pogoda; Martina Anton; Joachim Pircher; Alexander Pfeifer; Markus Woernle; Andrea Ribeiro; Petra Kameritsch; Olga Mykhaylyk; Christian Plank; Florian Kroetz; Ulrich Pohl; Hanna Mannell
Journal:  Mol Ther       Date:  2017-04-20       Impact factor: 11.454

Review 3.  Vascular-targeted nanocarriers: design considerations and strategies for successful treatment of atherosclerosis and other vascular diseases.

Authors:  William J Kelley; Hanieh Safari; Genesis Lopez-Cazares; Omolola Eniola-Adefeso
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-05-19

4.  Characterization of magnetic viral complexes for targeted delivery in oncology.

Authors:  Isabella Almstätter; Olga Mykhaylyk; Marcus Settles; Jennifer Altomonte; Michaela Aichler; Axel Walch; Ernst J Rummeny; Oliver Ebert; Christian Plank; Rickmer Braren
Journal:  Theranostics       Date:  2015-03-18       Impact factor: 11.556

5.  Cardiac Gene Expression Knockdown Using Small Inhibitory RNA-Loaded Microbubbles and Ultrasound.

Authors:  Jonathan A Kopechek; Andrew R Carson; Charles F McTiernan; Xucai Chen; Edwin C Klein; Flordeliza S Villanueva
Journal:  PLoS One       Date:  2016-07-29       Impact factor: 3.240

6.  Targeting of Magnetic Nanoparticle-coated Microbubbles to the Vascular Wall Empowers Site-specific Lentiviral Gene Delivery in vivo.

Authors:  Yvonn Heun; Staffan Hildebrand; Alexandra Heidsieck; Bernhard Gleich; Martina Anton; Joachim Pircher; Andrea Ribeiro; Olga Mykhaylyk; Dietmar Eberbeck; Daniela Wenzel; Alexander Pfeifer; Markus Woernle; Florian Krötz; Ulrich Pohl; Hanna Mannell
Journal:  Theranostics       Date:  2017-01-01       Impact factor: 11.556

7.  Nano-mediated delivery of double-stranded RNA for gene therapy of glioblastoma multiforme.

Authors:  Małgorzata Grabowska; Bartosz F Grześkowiak; Kosma Szutkowski; Dariusz Wawrzyniak; Paweł Głodowicz; Jan Barciszewski; Stefan Jurga; Katarzyna Rolle; Radosław Mrówczyński
Journal:  PLoS One       Date:  2019-03-19       Impact factor: 3.240

Review 8.  Gene therapy for cardiovascular disease mediated by ultrasound and microbubbles.

Authors:  Zhi-Yi Chen; Yan Lin; Feng Yang; Lan Jiang; Shu ping Ge
Journal:  Cardiovasc Ultrasound       Date:  2013-04-17       Impact factor: 2.062

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.